CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Innovac Therapeutics
Innovac Therapeutics logo

Innovac Therapeutics

Innovac Therapeutics: A biotech firm innovating vaccines using proprietary RNA technology.

Cambridge, MA, US🇺🇸
Founded
2022
Overview
Compare
Fundraising
Employees
Library

Founded with a mission to address unmet medical needs, Innovac Therapeutics is a biotechnology company specializing in the development of innovative vaccines. Utilizing proprietary RNA technology platforms and advanced manufacturing capabilities, Innovac aims to revolutionize the vaccine landscape. Their market focus includes creating effective solutions for diseases that currently lack adequate preventive measures, thereby improving global health outcomes.

Innovac Therapeutics has garnered attention from notable figures in the biotech industry and has attracted significant investment from leading venture capital firms. The company's achievements include the successful development of several promising vaccine candidates, which have shown efficacy in preclinical trials. Innovac's impact lies in its potential to transform vaccine development, offering new hope for combating a range of infectious diseases.

Innovac Therapeutics - Similar Companies

VaxEquity logo

VaxEquity

HDT Bio logo

HDT Bio

hdt.bio

Rnaimmune logo

Rnaimmune

rnaimmune.com

Iaso Therapeutics logo

Iaso Therapeutics

InvVax logo

InvVax

inv-vax.com

Attivare Therapeutics logo

Attivare Therapeutics

TheraJect logo

TheraJect

theraject.com

Chimeron Bio logo

Chimeron Bio

Moderna logo

Moderna

modernatx.com

Nutcracker Therapeutics logo

Nutcracker Therapeutics

nutcrackerx.com

Orbital Therapeutics logo

Orbital Therapeutics

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Combined Therapeutics logo

Combined Therapeutics

combinedtx.com

Thyreos logo

Thyreos

ReNAgade Therapeutics logo

ReNAgade Therapeutics

renagadetx.com

Innovac Therapeutics - Quick Facts

Who are Innovac Therapeutics' competitors?

Companies similar to Innovac Therapeutics include VaxEquity, HDT Bio, Rnaimmune and Iaso Therapeutics.

When was Innovac Therapeutics founded?

Innovac Therapeutics was founded in 2022.

Where is Innovac Therapeutics' headquarters located?

Innovac Therapeutics' headquarters is located in Cambridge, MA, US.

When was Innovac Therapeutics' last funding round?

Innovac Therapeutics' most recent funding round was for $18M (USD) in September 2023.

How much disclosed funding has Innovac Therapeutics raised?

As of Sep 1, 2023, Innovac Therapeutics has disclosed funding of $18M (USD). Undisclosed round amounts are excluded.

How many employees does Innovac Therapeutics have?

Innovac Therapeutics has 6 employees as of Feb 4, 2024.

Innovac Therapeutics - Classification

Ownership
  • Venture-backed
Technology
  • Biotech
  • RNA
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Vaccines
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified